HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperhidrosis treatment with bornaprine in the acute phase of spinal cord-injured patients.

AbstractSTUDY DESIGN:
Original article.
OBJECTIVE:
To test the use of bornaprine in the hyperhidrosis treatment in the acute phase of spinal cord-injured patients.
SETTING:
Patients with acute spinal cord lesions in the Spinal Unit of Pietra Ligure, Savona, Italy.
METHOD:
In 4 years, 12 patients have been treated, for a maximum period of 75 days, with dosages ranging from 2 to 4 mg day(-1).
RESULTS:
All of them reported long-lasting subjective benefits, without side effects, even after the interruption of the therapy.
CONCLUSION:
The bornaprine treatment, at 2 or 4 mg day(-1) dosage, has been effective and safe to contrast hyperhidrosis, in the acute phase of spinal cord-injured patients. This positive experience would require additional trials and a larger number of cases to gain a more solid support.
AuthorsR Sergi, A Massone, S Moretto, C Oggerino, F Bertolotto, L Losio, M Ottonello
JournalSpinal cord (Spinal Cord) Vol. 46 Issue 8 Pg. 571-3 (Aug 2008) ISSN: 1362-4393 [Print] England
PMID18332889 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Bridged-Ring Compounds
  • bornaprine
Topics
  • Adolescent
  • Adult
  • Aged
  • Bridged-Ring Compounds (therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hyperhidrosis (drug therapy, etiology)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Spinal Cord Injuries (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: